Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1588

SAR441344-hIgG1

Home » Antibodies » SAR441344-hIgG1

Background of SAR441344-hIgG1

The CD40 receptor and CD40L ligand are transmembrane proteins that are part of the tumor necrosis factor (TNF) receptor superfamily and are imperative to the induction and maintenance of inflammation. Frexalimab, a monoclonal antibody targeting the CD40-CD40L pathway, shows promise in treating various autoimmune diseases by reducing inflammation and tissue damage.

Specifications

Catalog Number:
KB-1588
Antibody Name:
SAR441344-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Wild Type
Target:
CD40L
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Fatima T, Mirza A, Fatima F, Karamat RI, Ahmad B, Naeem S, Shahid I, Akilimali A. Frexalimab (SAR441344) as a potential multiautoimmune disorder tackling mAB targeting the CD40-CD40L pathway undergoing clinical trials: a review. Ann Med Surg (Lond). 2024 Nov 12;86(12):7305-7313.